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ABSTRACT 
Background: Telomeres are nucleoprotein structures that protect the ends of eukaryote 
chromosomes. Shorter telomere length (TL) is associated with some age-related human 
disorders, but its relationship with obesity or adiposity parameters remains unclear. 
Objective: The aim of this study was to assess the relationship between TL and changes 
in adiposity indices after a 5-year nutritional intervention. 
Design and subjects: TL was measured by quantitative real-time PCR in 521 subjects 
(55-80 years, 55% women). Participants were randomly selected from the PREDIMED-
NAVARRA centre after they completed a 5-year intervention programme. 
Anthropometric parameters were directly measured by trained personnel at baseline and 
on a yearly basis thereafter. TL at baseline and changes in TL after 5-year intervention 
were assessed. 
Results: Higher baseline TL significantly predicted a greater decrease in body weight 
(B= -1.09 kg, 95%CI: -2.01 to -0.16), BMI (B= -0.47 kg/m2, 95%CI: -0.83 to -0.11), 
waist circumference (B= -1.15 cm, 95%CI: -2.28 to -0.01), and waist to height ratio (B= 
-0.008, 95%CI: -0.010 to -0.001) in multiple-adjusted models. In addition, changes in 
TL during the 5-year intervention were inversely associated with changes in the four 
anthropometric variables. The reduction in adiposity indices during the intervention, 
associated with increasing TL, was even higher among subjects with the longest 
telomeres at baseline. Logistic regression analysis showed that the risk of remaining 
obese after 5 years was lower in those participants who initially had the longest 
telomeres and increased their TL after intervention (OR=0.27, 95%CI: 0.03 to 2.03). 
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Conclusions: Our research suggests that TL is inversely associated with changes in 
obesity parameters. The assessment of TL can provide further insights for biological 
pathways leading to adiposity. We show for the first time an improvement of obesity 
indices when an increase in TL is observed after a 5-year Mediterranean diet 
intervention. 
Key words: Telomere length, adiposity, aging, nutritional intervention, obesity.
4 
 
 
INTRODUCTION 
Telomeres are nucleoprotein structures that cap and protect the ends of eukaryote 
chromosomes maintaining genome stability.1 Because telomeres shorten during mitosis, 
they are thought to reflect biological age. Thus, a slow and gradual loss of telomere 
length (TL) with increasing age in human peripheral blood cells has been reported.2 
However, it is also well known that telomere attrition is likely to be a modifiable factor 
as there is substantial variability in the rate of telomere shortening that is independent of 
chronological age.3 Therefore, short telomeres in peripheral blood cells have been 
described in patients with type 2 diabetes,4 cancer,5 metabolic syndrome6 and in 
individuals with increased cardiovascular disease risk factors, such as obesity.7 
Obesity is a common disease characterized by increased oxidative stress and a low-
grade systemic inflammation.8,9 These underlying mechanisms have been suggested to 
be the link for the association between shorter telomeres and obesity.10,11  Lee et al.12 
showed that high general and abdominal adiposity are directly related to lower TL, 
suggesting obesity may hasten the aging process. They found an inverse cross-sectional 
association between TL and body mass index (BMI), waist to hip ratio, total body fat 
and waist circumference (WC), independent of some metabolic risk factors. Other 
cross-sectional studies found that TL, measured in blood cells, is associated with an 
obesity phenotype but only among women.10,13,14  
Only a small number of studies have investigated the relationship between TL and 
changes in adiposity or anthropometric variables after an intervention. One prospective 
study reported that weight loss led to an increase in TL in rectal mucosa of obese men.15 
In the Bogalusa Heart Study, it was observed that weight gain and obesity accelerated 
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telomere attrition regardless of age.16 Similar findings were recently reported for 
Chinese women.7 Moreover, the single study conducted in the elderly found that shorter 
TL may be a risk factor for increased adiposity and weight.17  
To our knowledge, no prospective studies have assessed the association between 
changes in TL and changes in adiposity indices following a long-term dietary 
intervention. Thus, the aim of our study was to assess the relationship between TL and 
changes in anthropometric parameters after 5 years of a nutritional intervention, in the 
frame of a dietary trial: The PREDIMED-NAVARRA study. Our hypothesized 
expected change was an improvement in adiposity indices in the subjects who had 
higher TL at baseline or increased their TL during the 5-year period of dietary 
intervention. 
SUBJECTS AND METHODS 
Study design 
The PREDIMED study is a large, parallel-group, multicentre, randomized, controlled, 
clinical trial designed to assess the effects of the Mediterranean diet on the primary 
prevention of cardiovascular disease. The design and methods of this trial have been 
reported in a specific publication.18 Further details are also available at 
www.predimed.es. 
The study population consisted of women (60 to 80 years) or men (55 to 80 years) with 
no previously documented history of cardiovascular disease, but at high cardiovascular 
risk. They had either type-2 diabetes mellitus or at least three of the following major 
cardiovascular risk factors: current smoking, hypertension, elevated low-density 
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lipoprotein cholesterol, low high-density lipoprotein cholesterol, overweight/obesity or 
family history of premature coronary heart disease. 
The present analysis deals with a subsample from one of the eleven recruitment centres 
(PREDIMED-NAVARRA). The PREDIMED-NAVARRA recruitment centre included 
1055 of the 7447 subjects participating in the trial, being the first of the eleven centres 
to complete the enrolment of participants. Recruitment in the PREDIMED-NAVARRA 
centre took place between June 2003-May 2005, while in the rest of the centres it took 
place between October 2003- March 2009. Participants were randomly allocated to one 
of three arms: Mediterranean diet supplemented with extra virgin olive oil, 
Mediterranean diet supplemented with mixed nuts or a control group (low-fat diet). 
They were interviewed annually by a dietician, obtaining information about lifestyle, 
diet and incident diseases. Further aspects of the methods and design of the 
PREDIMED trial have been reported in detail elsewhere.18,19 
All subjects provided informed consent and the protocol was approved by the 
institutional review boards according to the Principles of Helsinki Declaration. This trial 
is registered at http://www.controlled-trials.com/ISRCTN 35739639. 
The present study assessed TL in 521 participants at baseline and after 5 years of 
recruitment, because the intervention was stopped in 2011 due to a decision of the Data 
Safety and Monitoring Board to stop the trial. The subjects were randomly selected, 
within those who had already completed 5 years in the intervention programme, from 
the three arms of the trial: Mediterranean Diet supplemented with Olive oil (n=211), 
Mediterranean Diet supplemented with mixed nuts (n=170) and a Control group which 
consisted in a low-fat diet (n=140).   
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Telomere length assessment 
TL was measured in genomic DNA extracted from human peripheral blood samples 
with a real-time quantitative PCR approach.20 This method uses Ribosomal Protein 
Large PO (RPLPO) single-copy gene as a reference for each sample.  
QuantiTect Syber Green PCR kit (Qiagen, Valencia, CA, USA) was used as master mix. 
The total reaction volume was 10 μL containing 10 ng of genomic DNA. PCRs for  
telomere (T) and single copy gene (S) expression were performed on white 384-well 
plates on an ABI-Applied Biosystems 7900 HT thermal cycler (Applied Biosystems, 
CA, USA). The final telomere primer concentrations were as follows: for telomere 
amplification tel1, 675 nmol/L and for tel2, 1350 nmol/L; and for the amplification of 
the single copy gene RPLPO: hRPLPO1, 800 nmol/L; hRPLPO2, 800 nmol/L. The 
primer sequences were tel1 (5’-
GGTTTTTGAGGGTGAGGGTGAGGGTGAGGGTGAGGGT-3’), tel2 (5’-
TCCCGACTATCCCTATCCCTATCCCTATCCCTATCCCTA-3’), hRPLPO1 (5’-
CCCATTCTATCATCAACGGGTACAA -3’) and hRPLPO2 (5’-
CAGCAAGTGGGAAGGTGTAATCC -3’). All primers were purchased from Sigma-
Aldrich, St.Louis, MO, USA. This method expresses TL as a T/S ratio calculated as 2-
∆CT. The work of Cawthon20 confirms that the T/S ratio is approximately 
[2CT(telomeres)/2CT(single copy gene)] = 2-∆CT, since the amount of the PCR product 
approximately doubles in each cycle of the PCR. 
As a standard, a calibration curve of the same DNA sample of reference (64-0.25 ng in 
2-fold dilutions) was included for each measurement to control the day-to-day 
variations. Standard curve with linearity R2> 0.98 was accepted. For quality control, all 
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samples were run in duplicate and checked for concordance between duplicate values. 
For obtaining stronger consistency, samples showing a high variation (more than 10%) 
were rerun and reanalyzed. The lower variation coefficient in the samples (2.68%), as 
compared with the change in telomere length in all the participants after 5 years of the 
nutritional intervention, supports the strength of the present methodology. 
Anthropometric variables assessment 
Anthropometric data were obtained by a trained nurse using standardized methods19 and 
they were measured in each of the yearly follow-up visits. The anthropometric variables 
assessed were weight, BMI, WC and waist to height ratio (WHtR). For this analysis, the 
change in adiposity indices was calculated as the variable after 5 years of intervention 
minus the variable at baseline.  
Confounders assessment 
The baseline interview included the assessment of cardiovascular risk factors and 
physician diagnoses of hypertension, diabetes and hypercholesterolemia. We also 
obtained the information about medical, socio-demographic, anthropometric, and 
lifestyle variables. Physical activity was assessed through a validated physical activity 
questionnaire21,22 and dietary habits were evaluated using a semi-quantitative 137-item 
Food frequency Questionnaire previously validated in Spain.23 
Statistical analysis 
We compared baseline characteristics of participants according to tertiles of TL. We 
calculated means and standard deviations (SD) or percentages for each variable across 
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the TL tertiles and assessed the statistical significance of the differences among them 
with one-way ANOVA and chi-squared tests, respectively. 
Pearson correlations analyses were performed to calculate the association between 
changes in obesity parameters and baseline and follow-up TL. Moreover, we fitted 
multivariable linear regression models to assess changes in four anthropometric 
variables (body weight, BMI, WC and WHtR) according to tertiles of TL at baseline. 
We also assessed differences in each of the four variables for losing or gaining TL after 
5 years of follow-up, according to tertiles of baseline TL. B coefficients and 95% 
Confidence Intervals (CI) were calculated, using those who had the lowest baseline TL 
as the reference group. For the multiple-adjusted model, the following potential 
confounders (all of them measured at baseline) were considered: age, sex, BMI (kg/m2), 
WC (cm), smoking habit (current smoker, former smoker or never smoker), diabetes 
status, hypertensive status, dyslipidaemia status, physical activity (METS-min/day), 
total energy intake (Kcal/day) and group of intervention (Olive oil, nuts and control 
group). We additionally mutually adjusted for each basal anthropometric variable, 
depending on the analysis, and multiple testing correction (Benjamini-Hochberg) 
analysis were performed. Finally, we also fitted multivariable logistic regression models 
to estimate the association between losing or gaining TL and the odds of remaining 
obese after 5 years of the intervention, according to tertiles of baseline TL, calculating 
odds ratios (OR) and 95% CI. A p value<0.05 was considered statistically significant. 
Analyses were performed using STATA version 12.0 (StataCorp, College Station, TX, 
USA). 
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RESULTS 
This PREDIMED-NAVARRA subsample assessed in our study included a total of 521 
participants (45% males). Baseline characteristics of these participants according to 
tertiles of TL are presented in Table 1. The three groups were well balanced but small 
though significant differences were found for age, body weight and total energy intake. 
Regarding average age, as expected, the greater the age, the lower the TL (p=0.047). 
Although baseline body weight was significantly different between groups, when 
analysing by sex no differences were found within either men or women. Energy intake 
was also different among categories of TL, but no differences were observed according 
to the macronutrient distribution. 
Significant inverse Pearson correlations of changes in body weight and BMI with both 
baseline and follow-up TL were found (Table 2). In addition, we fitted a multiple 
regression model to predict changes in adiposity indices at year 5 according to tertiles of 
baseline TL (Table 3).  Higher baseline TL significantly predicted a greater reduction in 
body weight (B = -1.11 kg, 95% CI:-2.03 to -0.19 kg for third vs. first tertile), BMI (B = 
-0.49 kg/m2, 95% CI:-0.85 to -0.13), WC (B = -1.24 cm, 95% CI: -2.39 to -0.09) and 
WHtR (B= -0.009, 95% CI: -0.020 to -0.001), when adjusted for age, sex and the 
corresponding anthropometric variable at baseline. These associations remained 
statistically significant in the multiple-adjusted model. 
We also found an association between changes in TL during the intervention period and 
the anthropometric variables after 5 years of the nutritional intervention, according to 
tertiles of baseline TL (Table 4). In fully adjusted analyses, participants who increased 
TL reduced more their weight (p trend=0.008), BMI (p trend=0.009), WC (p 
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trend=0.044) and WHtR (p trend= 0.051) than those who decreased TL after the 
intervention. Furthermore, we found that changes in TL after 5 years of the nutritional 
intervention were influenced by the initial TL. In fact, the observed reduction in 
adiposity markers, associated with increasing TL, was even greater in those who had 
longer telomeres at baseline.  
Interestingly, at the beginning 38% of the volunteers were obese. Nineteen percent of 
them successfully decreased their BMI under the threshold of 30 kg/m2 after 5 years of 
nutritional intervention, whereas 81% remained obese. The OR for remaining obese 
after 5 years, for those who initially had the longest TL, was 0.27 (95% CI: 0.03 to 
2.03) among those who increased TL, and 0.43 (95% CI: 0.10 to 1.89) among those 
who decreased TL during the follow-up (Table 5). Although these results did not reach 
statistical significance, a tendency was observed: the higher the baseline TL and the 
greater the increase of TL, the lower the risk of remaining obese. 
DISCUSSION 
In this study enrolling 521 elderly individuals, we found a significant inverse 
relationship between TL and adiposity indices using both initial and follow-up data.  TL 
measured at baseline and changes in TL during follow-up were significantly inversely 
associated with changes in adiposity indices including body weight, BMI, WC and 
WHtR after 5 years of a nutritional intervention. In addition, the risk of remaining obese 
after the intervention was lower in those participants who had the highest baseline TL 
and subsequently increased their TL during the intervention 5-year period. Tertiles of 
baseline TL were calculated in order to clarify whether presenting larger or shorter 
telomeres could be an indicator for adiposity after a 5-year intervention. We also 
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suggest that telomere attrition rate was influenced by the initial TL, as other studies 
have already reported.24,25 
To the best of our knowledge this is the first study analysing the effect of TL changes 
and baseline TL on changes in adiposity indices in the context of a long-term nutritional 
intervention. Mostly all of the literature considered obesity as a risk factor for telomere 
shortening. Recently, just one report proposed the opposite, as they suggested that 
shorter TL may be a risk factor for increased adiposity in the elderly.17 Therefore, we 
suggest that the assessment of TL could be a useful biomarker for a better 
understanding of the biological pathways implicated in obesity progression. 
Although the mean age of our population was 67 years, a significant correlation 
supporting the well-established age-related telomere loss was observed, regardless of 
accumulated diseases that could decrease the association between TL and age. 
Interestingly we detected an increase in TL in about 40% of the participants over the 5-
year follow-up period. Increased TL after a period of time has been observed recently in 
observational or interventional studies.3,24,26 Hence, TL is a dynamic factor and it can 
vary to both directions during a lifetime.24 
There are a few reports on the association between TL and obesity-related parameters, 
in which obesity has been linked to accelerated telomere attrition. In order to evaluate 
the role of obesity and abdominal adiposity in TL, several studies have used indirect 
anthropometric measures. The association between BMI and TL is controversial, in 
some studies no relation was observed in either elderly27,28 or middle-aged 
individuals29,30 but in other studies an inverse association was found.7,10,12,14 In the 
Bogalusa Heart Study, Gardner et al.16 found that a decrease in BMI was strongly 
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associated with an increase in TL (r=-0.423, p<0.001) in a middle-aged population. This 
is in agreement with our findings since we found a greater significant decrease in BMI 
in those subjects who increased their TL during the intervention period and had also 
higher baseline TL.  
There is just one study regarding the effect of weight loss on TL in midrectal biopsies of 
obese men.15 They suggested that losing weight may contribute to the prevention of 
telomere shortening and DNA damage, which is in accordance with our findings. On the 
other hand, other investigations7,31 reported that weight gain and obesity might 
accelerate aging since telomere shortening was greater.  
A significant inverse association with WC was observed, suggesting that reduced TL 
may contribute to abdominal obesity. Our finding agrees with the works of Nordfjall et 
al.14 in similar aged individuals, who showed that a higher WC is linked to shorter 
telomeres (r =-0.099; p=0.032) after adjusting for age. Several studies also reported a 
similar negative association between WC and TL,7,32,33 whereas others did not find a 
correlation with this parameter.27,29 
Another contribution of the present work is the use of a novel index for central obesity 
(WHtR) which is equally fair for short and tall persons, comparing to just measuring 
WC. Several studies have found that this is a more valid measurement than BMI34 
because it is a better discriminator for cardiovascular risk factors. The recently reported 
study by Cui et al.7 showed a significant inverse association between relative TL and 
WHtR (P trend=0.004) in Chinese women. Our trial showed for the first time an 
association between WHtR and TL including men and women, demonstrating the 
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higher the increase in TL the greater the decrease in WHtR after the nutritional 
intervention. 
Njajou et al.17 recently reported that shorter telomeres may be a risk factor for elevated 
levels of adiposity in elderly subjects (mean age 73 years). Specifically, this study 
showed TL to be associated with positive change in BMI and % body fat after 7 years of 
follow-up. These results are not in line with ours. Nevertheless, due to these 
discrepancies, it is unclear whether telomere gain is a cause or a consequence of 
changes in adiposity. Therefore, more studies need to be conducted. 
There are several strengths in our research. The prospective nature of our study with a 
long follow-up period enabled us to measure initial TL and TL after 5 years of the 
nutritional intervention. Our study is novel in the sense that it is the first time that TL 
was measured in a large number of subjects, in white blood cells and after a long period 
of time in the context of a Mediterranean diet intervention. There is just one study in the 
literature showing that a 4-week intervention with a Mediterranean diet prevents 
telomere shortening of endothelial cells in 20 elderly subjects.35 Moreover, we fitted 
multiple-adjusted models and multiple testing correction to minimize small differences 
among individuals and potential confounders. In the regression analysis, we controlled a 
substantial number of potential confounders, which is much more informative to 
suggest causal associations than simply obtaining correlation coefficients as most 
previous studies have reported. On the other hand, one limitation of the present study 
could be that measurements in elderly subjects at high cardiovascular risk may possibly 
be affected by existing chronic diseases. In fact, several studies did find that shorter 
telomeres were significantly correlated with smoking10,13 or other chronic diseases such 
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as dyslipidaemia, hypertension or diabetes.4,36 But this limitation was partly solved by 
doing multiple adjustments. 
In conclusion, our study shows an association between TL and obesity related 
parameters. We suggest that initial TL could predict changes in obesity anthropometric 
variables, proposing the assessment of TL as a biomarker of adiposity. In addition, we 
show for the first time that a decrease in obesity risk is linked to higher TL after a 5-
year Mediterranean diet intervention. Nevertheless, further research is warranted to 
confirm these findings and to better understand the possible biological mechanisms 
explaining these associations.
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Table 1. Baseline characteristics according to tertiles of telomere length. The PREDIMED-
NAVARRA study. 
Telomere length  T1 T2 T3 P 
n 175 174 172  
Age 67.8 (5.6) 67.0 (6.1) 66.2 (6.1) 0.047 
Sex (% males) 39 49 48 0.157 
Intervention Groups    0.098 
     MeDiet + Olive oil (%) 32 28 61  
     MeDiet + Nuts (%) 38 34 26  
     Control (%) 30 38 13  
Weight (kg) 73.0 (11.5) 76.0 (10.8) 75.4 (11.0) 0.029 
BMI1 (kg/cm2) 29.0 (3.4) 29.4 (2.9) 29.1 (3.4) 0.488 
WC2 (cm) 94.1 (10.1) 95.7 (9.8) 95.6 (9.4) 0.243 
WHtR3 0.59 (0.06) 0.59 (0.05) 0.59 (0.05) 0.945 
Physical activity (METS-min/d) 260 (188) 273 (201) 298 (198) 0.186 
Total energy intake (Kcal/d) 2184 (529) 2222 (515) 2355 (526) 0.006 
Carbohydrates (% Kcal) 40 41 40 0.358 
Proteins (% Kcal) 16 16 16 0.142 
Lipids (% Kcal) 41 40 40 0.823 
Smoking    0.090 
     Current smokers (%) 10 19 16  
     Former smokers (%) 21 26 20  
Dyslipidaemia (%) 64 67 67 0.749 
Hypertension (%) 87 80 83 0.264 
Diabetes (%) 35 34 40 0.510 
The table shows mean (standard deviation), or %. 
1BMI: body mass index, 2WC: waist circumference, 3WHtR: waist to height ratio. 
T1= < 78.25; T2= 78.25 to 198.08; T3= > 198.08. 
24 
 
 
Table 2. Pearson correlations coefficients of baseline and follow-up TL with changes in 
adiposity parameters after 5 years of the nutritional intervention. The PREDIMED-NAVARRA 
study. 
 
 
TL: telomere length, WC: waist circumference, WHtR: waist to height ratio. 
1 Adjusted for age. 
2 Adjusted for age and baseline TL. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Baseline TL1 ∆TL2 
∆Body Weight (kg) r= -0.110 (-0.194 to -0.024) r= -0.088 (-0.172 to -0.002) 
∆BMI (kg/m2) r= -0.119 (-0.205 to -0.034) r= -0.089 (-0.174 to -0.003) 
∆WC (cm) r= -0.141 (-0.224 to -0.055) r= -0.052 (-0.138 to 0.035) 
∆WHtR  r= -0.144 (-0.227 to -0.058) r= -0.053 (-0.138 to 0.034) 
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Table 3. Association between baseline telomere length and changes in anthropometric variables 
after 5 years of a nutritional intervention. The PREDIMED-NAVARRA study. 
The table shows B coefficients (95%CI). BMI: body mass index, WC: waist circumference, WHtR: waist to height ratio. 
1Adjusted for age, sex, basal BMI, basal WC, basal weight or WHtR, smoking (3 categories), diabetes status 
(dichotomous), hypertensive status (dichotomous), dyslipidaemia status (dichotomous), physical activity (METS-m/d), 
total energy intake (Kcal/d) and group of intervention. 
* p value < 0.05 after correcting for Benjamini-Hochberg multiple comparisons. 
 
Tertiles of baseline TL 
 
T1 T2 T3 
P for 
trend 
Weight change (kg)     
Absolute change 0.26 -0.14 -0.82  
Relative Change     
Age, sex and basal weight 
adjusted 
0 (Ref.) -0.31 (-1.23 to 0.60) -1.11 (-2.03 to -0.19) 0.015* 
Multiple-adjusted model1 0 (Ref.) -0.22 (-1.14 to 0.69) -1.09 (-2.01 to -0.16) 0.016* 
BMI change (kg/m2)     
Absolute change 0.12 -0.05 -0.33  
Relative Change     
Age, sex and basal BMI 
adjusted 
0 (Ref.) -0.16 (-0.51 to 0.20) -0.49 (-0.85 to -0.13) 0.007 
Multiple-adjusted model1 0 (Ref.) -0.13 (-0.49 to 0.23) -0.47 (-0.83 to -0.11) 0.009* 
Waist circumference change (cm)    
Absolute change 1.53 1.71 0.22  
Relative Change     
Age, sex and basal WC 
adjusted 
0 (Ref.) 0.34 (-0.80 to 1.47) -1.24 (-2.39 to -0.09) 0.008* 
Multiple-adjusted model1 0 (Ref.) 0.21 (-0.91 to 1.32) -1.15 (-2.28 to -0.01) 0.017* 
Waist to height ratio change     
Absolute change 0.009 0.011 0.001  
Relative Change     
Age, sex and basal WHtR 
ratio adjusted 
0 (Ref.) 0.001 (-0.006 to 0.008) -0.009 (-0.020 to -0.001) 0.005 
Multiple-adjusted model1 0 (Ref.) 0.001 (-0.006 to 0.008) -0.008 (-0.010 to -0.001) 0.014* 
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Table 4. Association between telomere length changes during follow-up and changes in anthropometric 
variables after 5 years of a nutritional intervention, according to tertiles of baseline TL. The 
PREDIMED-NAVARRA study. 
The table shows B coefficients (95%CI). 
1TL: telomere length. 
Adjusted for age, sex, basal BMI, basal WC, basal weight or WH ratio, smoking (3 categories), diabetes status (dichotomous), 
hypertensive status (dichotomous), dyslipidaemia status (dichotomous), physical activity (METS-m/d), total energy intake 
(Kcal/d) and group of intervention. 
T1= < 78.25; T2= 78.25 to 198.08; T3= > 198.08. 
 Tertiles of baseline TL  
 
T1 T2 T3 P for trend 
Weight change (kg)     
Change in TL during follow-up    
       TL1 decreased (n=314) 0 (Ref.) 0.10 (-1.19 to 1.39) -0.71 (-1.96 to 0.53) 0.197 
       TL increased (n=207) 0.29 (-1.03 to 1.61) -0.34 (-1.80 to 1.13) -1.58 (-3.21 to 0.06) 0.008 
BMI change (kg/m2)     
Change in TL during follow-up    
       TL decreased (n=314) 0 (Ref.) -0.06 (-0.57 to 0.44) -0.39 (-0.87 to 0.10) 0.111 
       TL increased (n=207) 0.01 (-0.51 to 0.52) -0.24 (-0.81 to 0.33) -0.71 (-1.35 to -0.08) 0.009 
Waist circumference change (cm)    
Change in TL during follow-up    
       TL decreased (n=314) 0 (Ref.) 0.68 (-0.89 to 2.25) -0.88 (-2.41 to 0.64) 0.083 
       TL increased (n=207) -0.01 (-1.62 to 1.61) -0.62 (-2.40 to 1.16) -1.95 (-3.94 to 0.04) 0.044 
Waist to height ratio change    
Change in TL during follow-up    
       TL decreased (n=314) 0 (Ref.) 0.003 (-0.007 to 0.013) -0.007 (-0.016 to 0.003) 0.053 
       TL increased (n=207) -0.001 (-0.011 to 0.009) -0.005 (-0.016 to 0.006) -0.013 (-0.025 to 0.001) 0.051 
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Table 5. Odds Ratio and 95% CI of remaining obese (BMI≥30 kg/m2) after 5 years of a 
nutritional intervention, according to tertiles of baseline TL and change in TL during follow-
up. The PREDIMED-NAVARRA study.  
1TL: telomere length. 
Adjusted for age, sex, basal BMI, basal WC, smoking (3 categories), diabetes status (dichotomous), hypertensive 
status (dichotomous), dyslipidaemia status (dichotomous), physical activity (METS-m/d), total energy intake 
(Kcal/d)  and group of intervention. 
T1= < 78.25; T2= 78.25 to 198.08; T3= > 198.08. 
 
 
 
 
  Tertiles of baseline TL  
 T1 T2 T3 
Change in TL during follow-up   
     TL1 decreased (n=119) 1 (Ref.) 0.50 (0.12 to 2.15) 0.43 (0.10 to 1.89) 
     TL increased (n=77) 0.91 (0.19 to 4.42) 0.48 (0.10 to 2.31) 0.27 (0.03 to 2.03) 
